Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Mengnan Lyu, Erlie Jiang, Yi He, Donglin Yang, Qiaoling Ma, Aiming Pang, Weihua Zhai, Jialin Wei, Yong Huang, Guixin Zhang, Rongli Zhang, Sizhou Feng, Mingzhe Han
Abstract
Auto-SCT with maintenance therapy after HSCT appears to be an attractive treatment option for patients with Ph+ ALL especially for those whose s3CMR was kept up to transplantation. For non-s3CMR patients, allogeneic transplantation may be more effective from lower relapse.
Topics & Concepts
MedicineTransplantationCumulative incidenceInternal medicineLymphoblastic LeukemiaHematopoietic stem cell transplantationStem cellAcute leukemiaGastroenterologyOncologyIncidence (geometry)LeukemiaSurgeryBiologyGeneticsPhysicsOpticsChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchPolyomavirus and related diseases